BiopharmaTrend.com

Auransa Inc.

Auransa Inc.

Private company
AURANSA INC.

Auransa Inc. is an AI-driven pharmaceutical startup focusing on developing precise medicines for cancer, aging-related diseases and other disorders. We are a group of veteran drug developers, data scientists, biologists, chemists, and more, who share the common purpose of developing treatments for serious human diseases in order to save lives and relieve suffering.

Auransa’s innovative approach to developing precise medicine for patients is based on two core proprietary technologies developed over the past four years.

SMarTR™ Engine is an artificial intelligence (AI)-driven platform for discovering patient subpopulations, novel targets, unique mechanisms of action and precise therapies.

CTSeek™ Liquid Biopsy is a companion liquid biopsy technology that will ensure we are identifying the appropriate patients for our clinical trials and enable us to monitor their responses to our treatments.


Founded
2014
Status
Private company
Geography
United States of America based
Funding
$2.810 M
Patents
1

Products

SMarTR™ Engine

SMarTR™ Engine is an artificial intelligence (AI)-driven platform for discovering patient subpopulations, novel targets, unique mechanisms of action and precise …

Read more

CTSeek™ Liquid Biopsy

CTSeek™ Liquid Biopsy is a companion liquid biopsy technology that will ensure we are identifying the appropriate patients for our …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page